Axitinib and Cabozantinib in the Treatment of Sunitinib-Refractory Patients With Metastatic Renal Cell Carcinoma (mRCC): Results of Matching-Adjusted Indirect Treatment Comparison (MAIC) Analysis of AXIS and METEOR Trials - 100098

Spotlight
Video

Axitinib and Cabozantinib in the Treatment of Sunitinib-Refractory Patients With Metastatic Renal Cell Carcinoma (mRCC): Results of Matching-Adjusted Indirect Treatment Comparison (MAIC) Analysis of AXIS and METEOR Trials

kidneycancer has 425 videos Subscribe Here

Loading........
Description: IRINA PROSKOROVSKY, MSC discusses Axitinib and Cabozantinib in the Treatment of Sunitinib-Refractory Patients With Metastatic Renal Cell Carcinoma (mRCC): Results of Matching-Adjusted Indirect Treatment Comparison (MAIC) Analysis of AXIS and METEOR Trials at the 2017 Kidney Cancer Association symposium in Miami, FL.
Shared By : kidneycancer
Posted on : 11/07/17
Added : 2 months ago
Category : Kidney Cancer



Recommended

Nothing found.